AnalgesiaNCT06556381
Efficacy of Trans Abdominis Plane Block for Post Cesarean Delivery Analgesia
A study testing TAP block in people with Analgesia, run by Qassim University at 1 site in Saudi Arabia.
Trial summary
Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women only
- Conditions the study is for
- Analgesia
- What is being tested?
- TAP block
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 1 Apr 2024to 30 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Age: 20-50 years
- Patients of >50 kg or <100 kg weight.
- Urgency: Elective, Emergent and Urgent cases
Who cannot join
- Patients of <50 kg or >100 kg weight
- Any contraindication to any of anesthesia medications
- Patient unable to understand numeric rating scale (NRS)
Trial locations and contacts
1 site in 1 country.
Saudi Arabia1 site
Qassim University Medical City
Buraidah, Al-Qassim Region, 51411
About this study
Official title: The Efficacy of Ultrasound-guided Transversus Abdominis Plane ( TAP) Block Versus Standard Analgesic Protocol for Postoperative Analgesia After Elective, Cesarean- Section Delivery- A Randomize Controlled Trial
Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.
Read the detailed description
Background: Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.
Rationale: Assessment and Improving the Pain Management Modality
Study objectives: In this study, determined the efficacy of TAP block in patients undergoing cesarean section.
Methods:
This study is a cross-sectional study. It is a multi-centric study as it was conducted in different Governmental hospitals.
- Conditions
- Analgesia
- Being tested
- TAP block
- Keywords
- Pain, cesarean delivery
- Medical subject headings
- Agnosia, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TAP blockProcedure or surgery
Women will receive TAP block.
| Study group | Role | What they receive |
|---|---|---|
| Group A, | Experimental | women who received TAP block. Receives: Procedure: TAP block |
| Group B | Active comparator | Received Usual modality of analgesics (Paracetamol, Tramadol, and Pethidine). Receives: Procedure: TAP block |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Score
NRS
Measured: 24 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Aug 2024
- Study start1 Apr 2024
- Primary completion30 Oct 2025
- Study completion30 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnalgesiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Qassim University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohammed Abaalkhayl, Qassim University
- Investigators
- Mohammed Abaalkhayl, MD, Principal investigator, Qassim University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06556381
- Sponsor's protocol ID
- 607/46/828
- Status last verified
- Aug 2024
- First submitted
- 1 Aug 2024
- Last updated
- 27 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 27 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Efficacy of Ultrasound-guided Transversus Abdominis Plane ( TAP) Block Versus Standard Analgesic Protocol for Postoperative Analgesia After Elective, Cesarean- Section Delivery- A Randomize Controlled Trial
- ClinicalTrials.gov ID
- NCT06556381
- Acronym / sponsor ID
- 607/46/828
- Conditions
- Analgesia
- Keywords
- Pain, cesarean delivery
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Qassim UniversityUniversity, hospital or other
- Study start
- 1 Apr 2024 (actual)
- Primary completion
- 30 Oct 2025 (actual)
- Study completion
- 30 Apr 2026 (actual)
- First posted
- 16 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.
Detailed description
Background: Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.
Rationale: Assessment and Improving the Pain Management Modality
Study objectives: In this study, determined the efficacy of TAP block in patients undergoing cesarean section.
Methods:
This study is a cross-sectional study. It is a multi-centric study as it was conducted in different Governmental hospitals.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A, | Experimental | Procedure: TAP blockwomen who received TAP block. |
| Group B | Active comparator | Procedure: TAP blockReceived Usual modality of analgesics (Paracetamol, Tramadol, and Pethidine). |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Age: 20-50 years
- Patients of >50 kg or <100 kg weight.
- Urgency: Elective, Emergent and Urgent cases
Key exclusion criteria (3 listed)
- Patients of <50 kg or >100 kg weight
- Any contraindication to any of anesthesia medications
- Patient unable to understand numeric rating scale (NRS)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TAP blockWomen will receive TAP block. | Procedure or surgery | Group A,, Group B |
Primary outcome
Pain Score
Time frame: 24 hours
NRS
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 May 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Analgesia
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
Not yet recruiting
Comparing Non-Medicine Strategies for Improving Low Back Pain
Chronic Low-back Pain (cLBP), High-Impact Chronic Pain (HICP)
Active, not recruiting
Efficacy of Laparoscopic-Assisted TAP Block in Laparoscopic Appendectomy
Appendectomy, Laparoscopic, Blockades Neuromuscular
Recruiting
SIRI Levels Following PENG Block in Pediatric Hip Surgery
Hip Dysplasia
Not yet recruitingPhase 2
A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)
Pain Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohammed Abaalkhayl, MD principal investigator
Qassim University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TAP block in people with Analgesia, run by Qassim University at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Score (time frame: 24 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2026.